4D Molecular Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JUPITER TOPCO LLC | 08/14/2026 | 5.75 M | $76.47 M | 100.00% | 8.44% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 5.05 M | $67.16 M | 0.00% | 7.42% |
| BLACKROCK, INC. | 08/07/2026 | 4.55 M | $60.46 M | 9.67% | 6.68% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 4.26 M | $56.64 M | 1.27% | 6.26% |
| NOVO HOLDINGS A/S | 08/14/2026 | 3.25 M | $43.21 M | -11.00% | 4.77% |
| STATE STREET CORP | 08/07/2026 | 2.91 M | $38.72 M | 7.51% | 4.28% |
| BVF INC/IL | 08/14/2026 | 2.88 M | $38.29 M | 0.00% | 4.23% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2026 | 2.51 M | $33.41 M | 100.00% | 3.69% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 2.25 M | $29.91 M | 40.12% | 3.30% |
| TRAILS EDGE CAPITAL PARTNERS, LP | 08/14/2026 | 2.23 M | $29.63 M | 70.99% | 3.27% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 2.10 M | $27.92 M | -4.40% | 3.08% |
| ARMISTICE CAPITAL, LLC | 08/14/2026 | 2.00 M | $26.60 M | 0.00% | 2.94% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.13 M | $15.01 M | 5.92% | 1.66% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 1.12 M | $14.90 M | 15.04% | 1.65% |
| EVERGREEN QUALITY FUND GP, LTD. | 08/14/2026 | 951.47 K | $12.65 M | 0.00% | 1.40% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2026 | 948.18 K | $12.61 M | 81.44% | 1.39% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 730.86 K | $9.72 M | 39.79% | 1.07% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 710.94 K | $9.46 M | 0.41% | 1.04% |
| CITADEL ADVISORS LLC | 08/14/2026 | 687.60 K | $9.15 M | 160.36% | 1.01% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 614.57 K | $8.17 M | 6.28% | 0.90% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 579.90 K | $7.71 M | 4.33% | 0.85% |
| DIADEMA PARTNERS LP | 08/14/2026 | 571.11 K | $7.60 M | 100.00% | 0.84% |
| NORTHERN TRUST CORP | 08/13/2026 | 562.93 K | $7.49 M | 64.58% | 0.83% |
| ACUTA CAPITAL PARTNERS, LLC | 08/14/2026 | 507.80 K | $6.75 M | 100.00% | 0.75% |
| NUVEEN, LLC | 08/11/2026 | 503.07 K | $6.69 M | -10.45% | 0.74% |
| MORGAN STANLEY | 08/13/2026 | 503.02 K | $6.69 M | 45.63% | 0.74% |
| RTW INVESTMENTS, LP | 08/14/2026 | 475.74 K | $6.33 M | 0.00% | 0.70% |
| CATALIO CAPITAL MANAGEMENT, LP | 08/14/2026 | 471.25 K | $6.27 M | 100.00% | 0.69% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2026 | 407.47 K | $5.42 M | 303.00% | 0.60% |
| JPMORGAN CHASE & CO | 08/12/2026 | 402.14 K | $5.18 M | -3.25% | 0.59% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 339.28 K | $4.51 M | 3.32% | 0.50% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 339.28 K | $4.51 M | 100.00% | 0.50% |
| OPALEYE MANAGEMENT INC. | 08/14/2026 | 334.44 K | $4.45 M | 197.83% | 0.49% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 276.24 K | $3.67 M | 2.58% | 0.41% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 08/14/2026 | 275.00 K | $3.66 M | 0.00% | 0.40% |
| UBS GROUP AG | 08/13/2026 | 256.67 K | $3.41 M | 62.33% | 0.38% |
| PROPEL BIO MANAGEMENT, LLC | 08/13/2026 | 252.65 K | $3.36 M | -33.59% | 0.37% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 242.35 K | $3.22 M | -8.94% | 0.36% |
| FEDERATED HERMES, INC. | 08/12/2026 | 222.42 K | $2.96 M | -84.47% | 0.33% |
| ARROWMARK COLORADO HOLDINGS LLC | 08/13/2026 | 202.86 K | $2.70 M | 0.00% | 0.30% |
| CITADEL ADVISORS LLC | 08/14/2026 | 201.50 K | $2.68 M | 587.71% | 0.30% |
| WOODLINE PARTNERS LP | 08/14/2026 | 200.00 K | $2.66 M | 0.00% | 0.29% |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 08/14/2026 | 176.85 K | $2.35 M | 100.00% | 0.26% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 163.55 K | $2.17 M | 713.29% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 152.34 K | $2.03 M | 14.02% | 0.22% |
| INVESCO LTD. | 08/14/2026 | 150.38 K | $2.00 M | -51.60% | 0.22% |
| PERIGON WEALTH MANAGEMENT, LLC | 08/07/2026 | 146.19 K | $1.94 M | -0.01% | 0.21% |
| PERSISTENT ASSET PARTNERS LTD | 08/07/2026 | 145.59 K | $1.94 M | 100.00% | 0.21% |
| VOYA INVESTMENT MANAGEMENT LLC | 08/12/2026 | 140.20 K | $1.86 M | 209.09% | 0.21% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 128.46 K | $1.71 M | 18.00% | 0.19% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
4D Molecular Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 203 institutional investors and hedge funds held shares of 4D Molecular Therapeutics Inc. The most heavily invested institutionals were:
Jupiter Topco LLC: 5.75 M
RA CAPITAL MANAGEMENT, L.P.: 5.05 M
BlackRock, Inc.: 4.55 M
GOLDMAN SACHS GROUP INC: 4.26 M
Novo Holdings A/S: 3.25 M
STATE STREET CORP: 2.91 M
85.79% of 4D Molecular Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 72.18 M shares in the last 24 months. This purchase volume represents approximately $630.13 M in transactions.